Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cassava Sciences Inc SAVA

Healthcare
Cassava Sciences, Inc. is a biotechnology company focused on Alzheimer's disease. The Company's science is based on stabilizing, but not removing, a critical protein in the brain. The Company is focused on its product discovery and development efforts on disorders of the nervous system. Its lead therapeutic drug candidate, simufilam, is under clinical evaluation for the proposed treatment of... see more

Recent & Breaking News (NDAQ:SAVA)

Pain Therapeutics Reports Q2 2013 Financial Results

Globe Newswire August 1, 2013

Pain Therapeutics to Present at the Jeffries 2013 Global Healthcare Conference

Globe Newswire May 30, 2013

Pain Therapeutics to Present at the Bank of America Merrill Lynch 2013 Health Care Conference

Globe Newswire May 13, 2013

Free Research Reports on PTIE, TSL, AL and GVA Issued by the Bedford Report

Marketwired May 13, 2013

Pain Therapeutics Files Form 8-K Regarding Correspondence From Pfizer, Inc.

Globe Newswire May 10, 2013

Free Research Reports on GNK, MHR, PTIE and SNTA Issued by the Bedford Report

Marketwired May 8, 2013

Smallcappower.com Daily Investment Idea: Healthcare Stocks with Increased Market Interest during Past Week Include Conceptus Inc, Pain Therapeutics Inc, and Trimel Pharmaceuticals Corp

Newsfile May 6, 2013

InvestorsGuru.com 46 Filtered Mid-Day Market Movers Recap

Investors Guru May 5, 2013

Free Research Reports on CIE, PTIE, THC and XYL Issued by the Paragon Report

Marketwired May 1, 2013

Pain Therapeutics Reports Q1 2013 Financial Results

Globe Newswire April 24, 2013

Pain Therapeutics Announces New Board Member

Troy Schwensen February 12, 2013

Pain Therapeutics Reports 2012 Financial Results

Troy Schwensen February 6, 2013

Merger and Acquisition Activity Expected to Rise in 2013 as Big Pharma Companies Flush With Cash

Marketwired January 11, 2013

Free Research Reports on PACB, PTIE, MY and ZLC Issued by the Bedford Report

Marketwired January 11, 2013